Childhood neglect leaves generational imprint
Distinct neural connectivity found in the babies of mothers who experienced neglect as children
Read morenews, journals and articles from all over the world.
Distinct neural connectivity found in the babies of mothers who experienced neglect as children
Read moreNew research suggests a unique program called Moms2B at The Ohio State University Wexner Medical Center shows a reduction in
Read moreNot only might youth with mood disorders of greater severity be more inclined to use cannabis than less severely affected youth, but cannabis use can also worsen symptoms and interfere with successful mood disorder treatment
Read moreIn a large study of pediatric cancer patients, researchers from Children’s Hospital of Philadelphia (CHOP) have analyzed the frequency, fusion partners, and clinical outcome of neurotrophic tyrosine receptor kinase (NTRK) fusions, which are clinical biomarkers that identify patients suitable for treatment with FDA-approved TRK inhibitors. The researchers found that NTRK fusions are more common in pediatric tumors and also involve a wider range of tumors than adult cancers, information that could help prioritize screening for NTRK fusions in pediatric cancer patients who might benefit from treatment with TRK inhibitors.
Read moreSupplement published in Pediatrics highlights evidence on how best to address this unique age group
Read morePhase 2 clinical trial involving CHOP and the Neurofibromatosis Clinical Trials Consortium showed cabozantinib reduced tumor volume and pain
Read moreMulti-stakeholder event will focus on national innovation ecosystem for pediatric medical device development
Read moreWhat The Study Did: Researchers investigated the association of home confinement during the COVID-19 outbreak with myopia (nearsightedness) development in
Read moreResearchers at Children’s Hospital of Philadelphia and the School of Engineering and Applied Science at the University of Pennsylvania have identified ionizable lipid nanoparticles that could be used to deliver mRNA as part of fetal therapy. The proof-of-concept study, published today in Science Advances, engineered and screened a number of lipid nanoparticle formulations for targeting mouse fetal organs and has laid the groundwork for testing potential therapies to treat genetic diseases before birth.
Read moreThe levels of small molecules called microRNAs (miRNAs) circulating in blood could help identify early on children with life-threatening forms
Read moreStudy demonstrates the efficacy and therapeutic potential of select ionizable lipid nanoparticles for delivering mRNA to treat genetic diseases before birth
Read moreStudy suggests that camps, which draw in 14 million children a year, may be an overlooked group when addressing communicable disease spread
Read more